Your browser is no longer supported. Please, upgrade your browser.
Settings
MDT Medtronic plc daily Stock Chart
MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E32.34 EPS (ttm)3.24 Insider Own0.10% Shs Outstand1.34B Perf Week-2.03%
Market Cap141.15B Forward P/E18.15 EPS next Y5.78 Insider Trans-0.90% Shs Float1.34B Perf Month4.51%
Income4.38B PEG3.44 EPS next Q0.83 Inst Own83.70% Short Float0.54% Perf Quarter12.29%
Sales27.93B P/S5.05 EPS this Y2.30% Inst Trans-1.14% Short Ratio1.51 Perf Half Y43.72%
Book/sh37.48 P/B2.80 EPS next Y42.91% ROA4.80% Target Price115.83 Perf Year-5.74%
Cash/sh9.66 P/C10.85 EPS next 5Y9.41% ROE8.70% 52W Range72.13 - 122.15 Perf YTD-7.62%
Dividend2.32 P/FCF78.07 EPS past 5Y7.70% ROI6.70% 52W High-14.20% Beta0.66
Dividend %2.21% Quick Ratio1.50 Sales past 5Y7.40% Gross Margin66.30% 52W Low45.29% ATR2.38
Employees90000 Current Ratio1.90 Sales Q/Q-13.20% Oper. Margin14.20% RSI (14)50.99 Volatility1.79% 2.14%
OptionableYes Debt/Eq0.57 EPS Q/Q-41.50% Profit Margin15.80% Rel Volume0.99 Prev Close104.80
ShortableYes LT Debt/Eq0.45 EarningsAug 25 BMO Payout66.90% Avg Volume4.84M Price104.80
Recom2.10 SMA20-1.14% SMA503.51% SMA2002.86% Volume0 Change0.00%
Sep-11-20Initiated Wolfe Research Peer Perform $115
May-14-20Downgrade DZ Bank Buy → Hold $92
Mar-30-20Downgrade Needham Strong Buy → Buy $134 → $109
Mar-25-20Upgrade DZ Bank Hold → Buy $90
Mar-05-20Initiated Citigroup Buy $124
Feb-13-20Initiated Goldman Sell $118
Jan-08-20Initiated SunTrust Buy $130
Jan-02-20Upgrade Guggenheim Neutral → Buy $135
Jun-05-19Upgrade Wells Fargo Market Perform → Outperform
Feb-04-19Reiterated Needham Strong Buy $120 → $117
Jan-03-19Initiated Deutsche Bank Buy $99
Jan-02-19Downgrade Citigroup Buy → Neutral
Dec-19-18Upgrade JP Morgan Neutral → Overweight
Nov-28-18Initiated UBS Buy
Oct-16-18Initiated Barclays Overweight $113
Aug-27-18Reiterated Argus Buy $95 → $108
Aug-22-18Reiterated Stifel Hold $87 → $96
Aug-13-18Upgrade Needham Buy → Strong Buy $103 → $119
Jun-27-18Initiated Bernstein Mkt Perform $88
Jun-06-18Resumed William Blair Mkt Perform
Sep-22-20 09:00AM  
Sep-21-20 11:28AM  
09:39AM  
Sep-17-20 07:00PM  
Sep-16-20 09:00AM  
Sep-15-20 11:05AM  
Sep-14-20 09:29AM  
09:16AM  
Sep-11-20 11:00AM  
11:00AM  
Sep-10-20 06:10PM  
08:00AM  
Sep-09-20 09:30AM  
09:30AM  
Sep-04-20 11:00AM  
09:23AM  
Sep-02-20 10:31AM  
08:38AM  
06:20AM  
Sep-01-20 08:35PM  
09:37AM  
09:32AM  
08:01AM  
02:27AM  
Aug-31-20 01:24PM  
10:39AM  
09:58AM  
Aug-29-20 09:00AM  
Aug-28-20 02:46PM  
Aug-27-20 01:29PM  
08:51AM  
06:21AM  
Aug-26-20 10:06AM  
Aug-25-20 04:22PM  
04:20PM  
04:00PM  
02:56PM  
02:08PM  
01:23PM  
01:06PM  
11:25AM  
11:22AM  
10:50AM  
10:45AM  
10:12AM  
09:29AM  
08:53AM  
08:05AM  
07:00AM  
06:58AM  
06:52AM  
06:45AM  
06:18AM  
04:04AM  
Aug-24-20 04:48PM  
02:56PM  
10:33AM  
07:00AM  
06:45AM  
Aug-21-20 08:00PM  
08:00PM  
10:56AM  
10:00AM  
08:03AM  
Aug-20-20 11:47AM  
10:55AM  
10:09AM  
Aug-19-20 05:11PM  
10:29AM  
Aug-18-20 12:31PM  
Aug-13-20 10:35AM  
08:17AM  
07:57AM  
Aug-11-20 11:00AM  
09:00AM  
Aug-05-20 07:00AM  
Aug-03-20 12:22PM  
07:00AM  
Aug-02-20 07:33AM  
Jul-27-20 05:50PM  
Jul-22-20 09:00AM  
Jul-17-20 07:18PM  
03:59PM  
Jul-15-20 11:01AM  
10:34AM  
07:30AM  
06:21AM  
02:30AM  
02:30AM  
Jul-14-20 09:29AM  
Jul-13-20 07:00PM  
01:32PM  
Jul-11-20 07:13AM  
Jul-09-20 10:05AM  
09:00AM  
Jul-08-20 03:52PM  
01:17PM  
12:29PM  
11:30AM  
10:27AM  
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PARKHILL KAREN LEVP & Chief Financial OfficerSep 15Sale107.7870275,66287,366Sep 16 05:40 PM
TEN HOEDT ROBEVP & President EMEASep 09Sale105.059,5631,004,59353,060Sep 11 06:04 PM
Surface Carol ASVP, Chief HR OfficerMay 29Sale97.722,000195,44047,443Jun 02 05:39 PM
OLEARY DENISE MDirectorApr 03Option Exercise44.131,81380,00866,544Apr 07 06:17 PM
ISHRAK OMARChairman & CEOFeb 20Buy113.688,771997,087605,190Feb 24 08:56 AM
Kuntz RichardSVP & Chief Medical & ScienceDec 24Option Exercise54.5542,7702,333,054109,571Dec 26 05:36 PM
Kuntz RichardSVP & Chief Medical & ScienceDec 24Sale113.5850,8565,776,10171,013Dec 26 05:36 PM
ANDERSON RICHARD HDirectorDec 06Buy113.295,000566,45095,231Dec 09 05:36 PM
WHITE ROBERT JOHNEVP & President MITGDec 02Option Exercise61.2652,1663,195,798104,234Dec 03 04:25 PM
WHITE ROBERT JOHNEVP & President MITGDec 02Sale110.6252,1665,770,82952,068Dec 03 04:25 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 15Option Exercise38.8136,8741,431,080225,136Nov 18 05:31 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 15Sale111.2536,8744,102,092188,262Nov 18 05:31 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 14Option Exercise40.412,10284,932189,464Nov 15 05:49 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 14Sale109.772,102230,731188,262Nov 15 05:49 PM
WHITE ROBERT JOHNEVP & President MITGNov 01Option Exercise36.3452,1651,895,47895,158Nov 04 06:28 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 01Option Exercise38.9038,9761,516,012226,036Nov 04 06:26 PM
WHITE ROBERT JOHNEVP & President MITGNov 01Sale109.3352,1655,702,99552,068Nov 04 06:28 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 01Sale109.5038,9764,267,872188,262Nov 04 06:26 PM
Surface Carol ASVP, Chief HR OfficerOct 11Option Exercise80.8584,2076,808,395121,920Oct 15 04:37 PM
WHITE ROBERT JOHNEVP & President MITGOct 01Option Exercise28.1752,1651,469,549104,082Oct 02 04:54 PM
Kuntz RichardSVP & Chief Medical & ScienceSep 27Sale107.5121,4252,303,49378,816Sep 30 05:52 PM
Lenehan James TDirectorSep 25Option Exercise44.131,81380,00855,464Sep 26 06:20 PM